Cancer as a robust system: implications for anticancer therapy (Q76394082)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993904%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

review article

1 reference

title

Cancer as a robust system: implications for anticancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993904%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Hiroaki Kitano

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993904%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993904%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993904%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993904%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993904%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

227-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993904%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrc1300

24 November 2019

exact match

0 references

cites work

Stochastic mechanisms in gene expression

1 reference

It's a noisy business! Genetic regulation at the nanomolar scale

31 March 2020

1 reference

Control, exploitation and tolerance of intracellular noise

31 March 2020

1 reference

Systems biology: a brief overview

31 March 2020

1 reference

Computational systems biology

31 March 2020

1 reference

Robustness in bacterial chemotaxis

31 March 2020

1 reference

Robustness in simple biochemical networks

31 March 2020

1 reference

Robust perfect adaptation in bacterial chemotaxis through integral feedback control

31 March 2020

1 reference

Robustness as a measure of plausibility in models of biochemical networks

31 March 2020

1 reference

Robust oscillations within the interlocked feedback model of Drosophila circadian rhythm.

31 March 2020

1 reference

Circadian clocks limited by noise

31 March 2020

1 reference

The segment polarity network is a robust developmental module

31 March 2020

1 reference

Robustness, flexibility, and the role of lateral inhibition in the neurogenic network.

31 March 2020

1 reference

Simulation of prokaryotic genetic circuits

31 March 2020

1 reference

Robustness of a gene regulatory circuit

31 March 2020

1 reference

The large-scale organization of metabolic networks

31 March 2020

1 reference

Error and attack tolerance of complex networks

31 March 2020

1 reference

Cancer robustness: Tumour tactics

31 March 2020

1 reference

Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells

31 March 2020

1 reference

Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor

31 March 2020

1 reference

Tumor progression: a brief historical perspective

31 March 2020

1 reference

Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations.

31 March 2020

1 reference

Extensive cytogenetic heterogeneity in a benign retroperitoneal schwannoma

31 March 2020

1 reference

Metapopulation dynamics and spatial heterogeneity in cancer

31 March 2020

1 reference

Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.

31 March 2020

1 reference

A genetic model for colorectal tumorigenesis

31 March 2020

1 reference

Genetic instabilities in human cancers

31 March 2020

1 reference

Somatic recombination redux.

31 March 2020

1 reference

A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity.

31 March 2020

1 reference

Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy

31 March 2020

1 reference

Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy

31 March 2020

1 reference

Stem cells, cancer, and cancer stem cells

31 March 2020

1 reference

31 March 2020

1 reference

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

31 March 2020

1 reference

Multidrug resistance (mdr) genes in human cancer

31 March 2020

1 reference

MDM2 oncogene as a novel target for human cancer therapy

31 March 2020

1 reference

The p53-Mdm2 pathway: targets for the development of new anticancer therapeutics.

31 March 2020

1 reference

Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study

31 March 2020

1 reference

Tumors are unique organs defined by abnormal signaling and context

31 March 2020

1 reference

Putting tumours in context

31 March 2020

1 reference

Tumor hypoxia: a target for selective cancer therapy

31 March 2020

1 reference

Biological consequences of tumor hypoxia

31 March 2020

1 reference

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

31 March 2020

1 reference

Hypoxia--a key regulatory factor in tumour growth

31 March 2020

1 reference

Hypoxia-induced pathways in breast cancer

31 March 2020

1 reference

Lack of effectiveness of adjuvant alternating chemotherapy in node-positive, estrogen-receptor-negative premenopausal breast cancer patients: results of a multicentric Italian study. The Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group

31 March 2020

1 reference

Less efficacy with alternating regimen as adjuvant chemotherapy in stage II node-positive breast cancer: results at 8 years (Pronacam 85)

31 March 2020

1 reference

Cytogenetic and molecular mechanisms of resistance to imatinib

31 March 2020

1 reference

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

31 March 2020

1 reference

Roots of clinical resistance to STI-571 cancer therapy

31 March 2020

1 reference

Cancer dormancy: opportunities for new therapeutic approaches

31 March 2020

1 reference

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

31 March 2020

1 reference

Tumour dormancy: not so sleepy after all

31 March 2020

1 reference

Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling

31 March 2020

1 reference

Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

31 March 2020

1 reference

T-cell immunity in the induction and maintenance of a tumour dormant state

31 March 2020

1 reference

T cell memory, anergy and immunotherapy in breast cancer

31 March 2020

1 reference

Angiostatin induces and sustains dormancy of human primary tumors in mice

31 March 2020

1 reference

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

31 March 2020

1 reference

Promises and pitfalls of anti-angiogenic therapy in clinical trials

31 March 2020

1 reference

Solitary cancer cells as a possible source of tumour dormancy?

31 March 2020

1 reference

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

31 March 2020

1 reference

Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators

31 March 2020

1 reference

Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer

31 March 2020

1 reference

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance

31 March 2020

1 reference

Engineered gene circuits.

31 March 2020

1 reference

Sustained loss of a neoplastic phenotype by brief inactivation of MYC

31 March 2020

1 reference

Cancer. Addiction to oncogenes--the Achilles heal of cancer

31 March 2020

1 reference

Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis

31 March 2020

1 reference

"Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally

31 March 2020

1 reference

31 March 2020

Surfing the p53 network

1 reference

The complexity of p53 modulation: emerging patterns from divergent signals

31 March 2020

1 reference

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

31 March 2020

1 reference

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

31 March 2020

1 reference

Negative control of p53 by Sir2alpha promotes cell survival under stress

31 March 2020

1 reference

Human Sir2 and the 'silencing' of p53 activity

31 March 2020

1 reference

Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases

31 March 2020

1 reference

How does calorie restriction work?

31 March 2020

1 reference

Toward a chronotherapy of neoplasia: Tolerance of treatment depends upon host rhythms

31 March 2020

1 reference

Cancer chronotherapy: principles, applications, and perspectives

31 March 2020

1 reference

Bifurcation analysis of a model of mitotic control in frog eggs

31 March 2020

1 reference

Complexity and robustness

31 March 2020

1 reference

Reverse engineering of biological complexity

31 March 2020

1 reference

Genetic instability and darwinian selection in tumours

31 March 2020

1 reference

Error catastrophe and antiviral strategy

31 March 2020

1 reference

Multiple mutations and cancer

31 March 2020

1 reference

Targeting HIF-1 for cancer therapy

31 March 2020

1 reference

Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein

31 March 2020

1 reference

Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells

31 March 2020

1 reference

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

31 March 2020

1 reference

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

31 March 2020

1 reference

Involvement of chemokine receptors in breast cancer metastasis

31 March 2020

1 reference

Tumor reversion: Correction of malignant behavior by microenvironmental cues

31 March 2020

1 reference

Chemokines: agents for the immunotherapy of cancer?

31 March 2020

1 reference

The microenvironment of the tumour-host interface

31 March 2020

1 reference

Cancer immunotherapy: the past, the present and the future

31 March 2020

1 reference